[CCoE Notice] Spilling the T (cell)!

[UH Cullen College of Engineering]

Dear Engineering Faculty and Students,


Please review the below opportunity at your convenience.


https://urldefense.com/v3/__https://oncologyinnovation.splashthat.com/ecfe?utm_campaign=WCS*20US*20Weekly&utm_medium=email&_hsmi=150586274&_hsenc=p2ANqtz-_NE3X16N9581Jn5kFgi99pcy0QRo_7Mp6Ol3yRAYrTMPas5JcPS9no0pDRB12e9GB3sPWS6FEfadaJOzw0VfIdvsLgGw&utm_content=150586274&utm_source=hs_email__;JSU!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBqCccDnk$ 



Thank you.


*******


This message was sent from an unmonitored address. Do not respond directly to this message.





From: Johnson & Johnson Innovation <jji at jnjinnovation.com>
Reply-To: "jji at jnjinnovation.com" <jji at jnjinnovation.com>
Date: Thursday, August 19, 2021 at 10:08 AM
To: "sgghurye2 at uh.edu" <sgghurye2 at uh.edu>
Subject: Spilling the T (cell)!



Join our event as we ride the next wave of scientific innovation in hematology

Not rendering correctly? View this email as a web page<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsD75nz3BV3Zsc37CgJ9jVXyL3x89VFj1W2svNB_5gRdYmW6hrPbs8fs3zJW7q-nSP1f1Mg_W5fTVhk6Gzg2xW4RyTKX6gpVQwW6L9p673W0R26N3mvZnCvGgSSW27d6CV2lbfg3V9XF4C3NsjfkW6r403r9fpyzLW8sTRlF84q4prVY34Z71_kN-hVntlt06hY0QDW94WQ1t5FM0BZW1NC4rM2kXPSnN8C5B3DfcR6HW2RWSZG97J2tLW6xqzRW3lC0FCW5hl-517XVm2PW1TyMFx5m837KN6bgB5F-1rqJW4dKlc-66ZZ8bW3cG-J33DNpyYW21Dws392NHN8VB_Qxh3rWgCrW3qxQ6L2nVbYTW7bpq-V4TLHT4W80BVt57rJR-8W1JDnt25g9n6_W9kl8Vm73Dx-ZW4bpZw43ZbLCKW5Xk33S58nSWXW73Hz9W5mV67nW1SYqPH7zBG3zW6GKtfy7tDbc-3nmW1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeWgx4nJL$> here<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsD75nz3BV3Zsc37CgYcJW5tBS7k4B43mWW2Nt6JT7jcLL-W7fSJnd1h2xZ2W4vDggx4N2DSjN7CR7CkPYYjzN6_tv65ZhzB-Vr9LPQ5Y4J03W2Vh9QK6Jy29wW62WDXs63WdPFW8lzXjT2pCsfLN3jDrQwvjXTwN62Zc3Z4VH8YN8xHGzLfXCgWW8MB2Wg59mzrLW43sD-h2Y5C4TW99pkcP8QP6pZW5g81S13Zpg6mW3SC-9p3wWX08W4g8Ry711pvMdW3QFrd11DYpftW3QT3Jz4XqdjhW8Fj3xY2CjrP1W68286f8_DwQwW2jYz1W5zBjTfW53qLGx5RJtY8W8cpVQ-1T6MN5N330Xfgzw8D0W1g--R27K3y2lW2Lvv7Q5wdqY9W8bWj5F2X5yh1N3H7s0yzz2hsW2J1VgR39rpByW6phCPn7MJ2JhVplXm12VS9WLN8ScvWff5X0CW2WmRsX6KDn_C3jNZ1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeTCbUJQx$>.





[J&J Innovation]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsD73q0zpV1-WJV7Cg-1NW2BCb5X1Z0CnLW8ygn1C5PLdRpW4lq0nb473Wz1W221F2Y5YfXD4VX1fdW4w8RFqW5z_7Qv7g984MW2nQjcF3PHKXWW679H475vpQ7pW23hjk11njCnHW890lG-4kJFClW6BTPwK29h2c4W6PDP-76P4Qw5VKdQHL7Cph2KW1Nd1pX8JvLJVW1JYnnJ6v4pTvW7q8F186KN6fwN944zscbBRKpW9ccwpF52Sh8xW4TPFzD828MPwVsq3Rq9gwnrK35Yw1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeQr-kxGL$>



REGIONAL BRIEF | West/Central US





[Next Wave of Immune Engagers in Hematological Malignancies]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgNvdW3NrgSf9fnRtFW3pQ8gS7mF2LWW7C5Qy65kvNQrW1Ydm-48bhZB-W6xmmRB1z1JbdW2_XY2V8yqmZQVb92lK2X9Z83W14BN5d6Lk09vW3zNg655TjyppMgpGSJjbj3PW48L7Hj6Gd8ckVx2VkR3D5_XhW2xzQjC7wygt0W7_2XC03zNnkdW19VmB62fdykNW3JvLbh68kZ8SN4cCsm3SpL-rW6dW6-d9jqfgJW5ZXDMs47CCkpW1_mBS43fGnqxW8ZRGYW1jybqzW4Bsr-Z5tSLxL34Tx1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeeel4qu8$>





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Icons/Clock*20Icon*20-*20Black.png?width=40&height=40&upscale=true&name=Clock*20Icon*20-*20Black.png__;JSUlJSUl!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB3qWjluk$ ]



Sep 7 | 6:00am - 9:00am PT | Online Event







Next Wave of Immune Engagers in Hematological Malignancies





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/CTA-Buttons/CTA*20Register*20Black.png?width=220&height=70&upscale=true&name=CTA*20Register*20Black.png__;JSUlJQ!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB9RMO5P0$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgZ8LVwxlBC9khTcnW3_wxDx6lJhMKVmQ2b0738dS_N1-J-mX-lqGJW6yjg2j10zstqW3tbGkV1_cznxW7-8KBM2JZddVW8HkSg45xJ5lNW8L15K-8dm6xJW1dRrTH4KjYt_W4_Jx1b96s7v1W3p6kpw4twdKRW4_0SLw69JBrSVp2HFq42JldJV5RHJx218dfYM3ktdvw2ppPW3whSZn1Q_l2PW6trNyx5vS7gkW3Mmrbr5vzYZpW7fF70h6yYnrQW8JbV9Y6gcn1bW7Q628s40D-d73c6s1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeWRD3ifA$>





Hear from Janssen R&D and experts within oncology and hematology discuss the next wave of scientific innovation around hematological malignancies. Johnson & Johnson Innovation continuously seeks to nurture new connections and collaborations in pushing the boundaries in immune cell engaging therapeutics, welcoming entrepreneurs, start-ups, researchers, and scientists.






[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Speakers/Yusri_Elsayed_250x100.png?width=500&height=200&upscale=true&name=Yusri_Elsayed_250x100.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBLlSQps4$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgZd0W1svBBp79JyqZW3S5Q8n4mj9KCW1ctCD26g_yPqW3WGLKS1nrc65W6bLJ8w696_NrW7cr8d23Y3hdcW9fmPKw6LPK6QW6d5_G75M8cfjW8_8Jfv5dyYx3W98msL931zZSwW6VYjG-6GHT3FW8CMH_R2rfyBwW2lg75F8dhlmsW19SvvF7b_hc2W1X3ylJ84rFTfW15ZPWX1DjSRLN39BMrnQxVlHW8zKPHl78LxKKW9kWksR5jwmGWW5vcl3B4XLwkQW3vBdNG1yyRBcN5Zq1lnzYgqJ35vj1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeRCsLW59$>



[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Speakers/Sonal-Patel_250x100.png?width=500&height=200&upscale=true&name=Sonal-Patel_250x100.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBfOfdlXs$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgHL8W1gr1JG78btCGW3zFx1y59SZ_gW6K5nyL4XJzQMW42sJKm6JNVh2W5WVrd97Z9cnNW90RWSp5VP16tVdhsMc2KWvzVVZMc-Q47LKMtW6B8_Nc5gmy2dW8z-FCm1bxfs-W1jw2p47tL4D6N2ZZK8b-HT9DW56Qgr22thYDkW7R-jV81_dy6RW4K1-Jb5WWbMNW4RwR_t5CJBj6W1GmW_G39TzxVW2p31JJ7tBkYPW5R2cN91qJdlnW87SSYy1JkDthN4llVZ-32N1YW8nVFdg9jkb9B39YV1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeSvFCu9p$>



Yusri Elsayed
Vice President, Hematologic Malignancies Disease Area Stronghold Leader, Janssen R&D



Sonal Patel
Vice President, Scientific Innovation Oncology EMEA, Janssen R&D, Johnson & Johnson Innovation, EMEA





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Speakers/natalie_mount_250x100.png?width=500&height=200&upscale=true&name=natalie_mount_250x100.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBHqkCKVg$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgTGRW1DZ_jJ6ZCXMtW22cGLQ42RGlvW6BlJ441Y2ydgW45y7wf4k7Wg0W5Sg_jv5WyJQNW3DvWq_1kgTFBV8p7QR3NWRVBW5tv4gX8hVRGHW4B3m6D8gDghgW70kfcp6tq1gqW6y9BsM4z2ZCsVntSQ63xgcQmW8LMYXz3mtzb0W4mJx3y1_mj9SW80Z59s8z2Q-kW1HBq3F3g5SWbW5cmszl7BRQv3N780tf7fjbTHW25KvyY7ddsMxW6QHtTJ7G5tlGW13lcmK8z2_q_W5C8r0B7sJ0Hr33P81__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eecvv-tTJ$>



[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Speakers/Paul_Parren_250x100.png?width=500&height=200&upscale=true&name=Paul_Parren_250x100.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBUPEZT_4$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgHmGW1T99Yv23KBcjW37f04B7sy0rXW7-9v057Cn7HkW7W-7MZ67_cWBW7Bl50Q10Cvn5N99K-0_dxB1bW1yjf2c7cMSHbN1prYNvTPRnZN4b4D_MMyQ54W6grqHm7243jMVf_W3N6Mn1NRN5pdphPHrcBVW6fMHs_6NQkXBW7JH3K638GJWNW2cyDlQ3kxcW0W2vRzfg5rcYLfW5xQkkT5-QRszW2yh_3c6T5K7pW1_fDPG3D7Gv1W6lmCRd3KhjDhV6Vf6n1sk4QrW36-SYK1Xqzk837x91__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eebilkznL$>



Natalie Mount
Chief Executive Officer,
Adaptate Biotherapeutics



Paul Parren
Executive Vice President and Head of R&D,
Lava Therapeutics





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/CTA-Buttons/CTA*20Register*20Black.png?width=220&height=70&upscale=true&name=CTA*20Register*20Black.png__;JSUlJQ!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB9RMO5P0$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgXWmVvVPNN2Hpyk1W8dMT3N7c372WN7pT9g7xrRvlT4zcv5R9VysW65HH5K9dVQVGW5p6Km07S7_20W35pFXT5q2nK2W7hFm5R6hpQxxW6xs7Jt3pRynmV3kKjm2K45ZfW90JYrR4267kwW2gzvq23HBSRwW55WMMX6g8BlwW2GdDJc7PT_mQW9gt7T54VkKFTW1s4LQF69Hs0dW8s-vxL2jvk4jW747PXb1Lg1PGW9gr2wZ2ncMrYW8pmTHm4t3CHlV_D2q42C0SpdW5fgjxM2fH_Dq390f1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eebuLmA3v$>









[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/i_GreyLineSeparator.png?width=1200&height=20&upscale=true&name=i_GreyLineSeparator.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBeOSMWX8$ ]





In The Spotlight





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Spotlights/medical_drone_520x180_v1.png?width=1040&height=360&upscale=true&name=medical_drone_520x180_v1.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBJ8VDg6g$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsF13q0BhV1-WJV7Cg-L6W7wJVcX3-ntC6W6WMDly7cK0sRW5Zw6gV4lxCG_N2Lyl0-srvT4W2XXBf03lqpCVW6BVr_q5XvYvsW6nr0Ff4K359RW1-xVhL95lL-bN3Slv_9vgKvsW311HGl629PSSW167kxX2DRtH4W31xb6s8rD6dkW2kmJ3W5Wlz6yW1n9D9w3yvl7KW1kkj4x1xJWRCW99dbSb1vjPT4W74YttZ7y-KbXW1QckkK6BVrwdW8QCj3T4VdClcW5ydfV21vtby7N22XSQ1kYZXXW3NByKP5xzHZ9W5GfNZt6hfyJMV43LvK8pJp5dW65hFWH8RLLm-W33FLrg5z5BYf3m-J1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeb9ZPwq8$>





How drones can deliver lifesaving HIV drugs in remote communities in Uganda<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsF13q0BhV1-WJV7CgLZ8W6k2nkd7RkMtBW6S5M211FwRRRW4jKZ5W3NXLFRW1t8p196Dbm_mN701DGhRspsVW1chGSh8HmtMxW3BSWbW8N9vGHN7-fYZy4B985W7XLQ1n18y4ZRW8BwMdQ8fr7rHN2_JT0DtnPJRW5zCDsc7ljW6MN8gBq8_KN1slW2PMdJh4HWdv9N8l0jwrdvqy1W2WSv-05kCyt0N1pbNSk_Zx3_W6QZ5Pw3L3xjYW1PzTjt5hztQ2W6qHnJ13jCl6FN6RPxw4VsDRnN70PFJRSJLWDW34MGhk6bP4lKW4BcGYH71_h0GN9hS-dmpVZnjW4JrJy_3mykBr3nWF1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eecq941GP$>. New Johnson & Johnson-supported program leverages drones that can serve 20 landing sites across 5 islands, reaching more than 3,700 people in a single day





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/CTA-Buttons/CTA*20Discover*20Black.png?width=220&height=70&upscale=true&name=CTA*20Discover*20Black.png__;JSUlJQ!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBQaxBQlk$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsF13q0BhV1-WJV7CgHDXW7T2h5z3h8hh_W1xS5kk5Q442DVyJv3b7kl5MQW6cBY1R3BdHMZW26Cl368yjHsrW1Cjk5T6cYJZFW6S_Bjm6_vyh6W1nGkT45hyfCjW1Rpmv42vPhb5W95LnyB3_Hy-BW3R5Vhf4dwc7QW6mnSDf54PHhgW1th2Dt2GygbGW5lTv4v4Jr5ZGN2Lg-CJdjQ5bW7FLcrn5ZlhM9W4F-STW6B8TTWW1NL8sM19yG8yW60vG2p80BrzpW5xVnlC1dQD9HW23fDPL1B62D0W3FYr088F0QWsW2x0_zh60ys1rW7MqG843N_GJFVqKXr860b7TTW6XdKx23ypNC_3ll41__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeds6ZHyk$>





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Spotlights/nasa-250x100.png?width=500&height=200&upscale=true&name=nasa-250x100.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB8tW2HJU$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFD3q0BVV1-WJV7CgS3_W5gkF5c4WTQbFW1BtY1-1xMGxnW79Q0db6NkGr7V43zYj6hBzKpW6YdMzQ3TspJWW9jlxYk650zF1W82wz7H95Nw_TW2GR2MX5wmTSpW8y-p4R92BVF1W8qCJQ12PmpQ7W9jpSfP3qJx5cW8zpg1N4s69WkV-jfK28X2WLkVCwg3R8wRP32W2Rx4FF4vdZxMW10cCjx7PpkFvVQl1Jf4P_Xh2W31t77N5GZLB-W54-vpv25-_5tW1D66zf3cQ6lxW3GXNzJ56JMxSW8cxb1H2Sc3vdW5XCV5V4tGF27W5vYccx54dsQKW5F66tk3VpYvPN5q4Ds5J-qrYW3d3p8J8lsR2QW3Xt7LH18M-HBN15VzFjDxMwcW4g68xH2_-RqP37kZ1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeQI1bm24$>



Watch the Forge the Future: Expanded Pathways<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFD3q0BVV1-WJV7CgLycN6NgChQNHsqbW18_2rF5kJ9QBW5C-g3C57yT_8W2mCSGP5QczTZW6NWyLB1kKxnqW1XHrqD2ntH5dW9cGx4_7pKs2gW97nRbB8nyLRyW6Fm1Vt7xhMYRW9458XD65w7FmN2vM8WdKlqnwW7mH1dn36-ZrhW1Qkb211QNvq0V45pP58CBMP9W4dgMmp4Gld29VPsZ2C4YSMzKW9bzGtB2rZXlmW2HSzd5569KCNN8pjHRV6vkvLVZRx4y7N0vCXW83g0NM1Q7l6_W8dVmP72SNwLvW3VPbKp4JL1pSW1M53fP7xBhHVW5Lc3tZ5JWnJLVjMvCb2CKf9YW68-ypz4CZsK5W5NsLtj2ZrKMMW7WC42x2GNwRbW8z_xJ_3MNfGF3pv81__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeaiEtH5D$> via on-demand webinar to learn what it takes to join BLUE KNIGHT™, our joint initiative with BARDA



[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/CTA-Buttons/watch_160x45.png?width=240&height=70&upscale=true&name=watch_160x45.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBczunsr4$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFD3q0BVV1-WJV7CgCtHW13M4fv3_mbH6N4_qsHGCwG85W1nx2Wv8p5YQbW3-sKpk7xN-1HW9kd_MR4sqGQ3W1K0xs75YxVv1W88fd2K6NnjNXW6pfhfy33bhlQW4LBjqc2yqysnW31XJP78w6FvCW6_nTDm5yc9TZW5T3P1P5gHQjJW47cy745d82XdW4H-9cR21rLqyW2tP-j_4WrfQYW6CJFdZ2y86YnW397XTv5VHfxcW1ZqgH47wYG41W2Hs5556sTvbFW6K43RD4xwzcDW3Ry2dF4TKNZRW8rFW5g7YFJ3yW2xYpYw47qL1QW87rYm07cLPNnVwnlDW80zb71W7w4d637zwLqjW7ZK-GQ1Y7ys_W1Gk-wC8H6JypW7cpn5F4F7YmFW9kbSzD49ZSrz3lz21__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeXrKNuze$>





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Spotlights/meeting250x100-1.png?width=500&height=200&upscale=true&name=meeting250x100-1.png__;!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OBGSif4m0$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsF13q0BhV1-WJV7CgV88W2YwkJc2pFPLKW9cbwq25B2_M3W51jMXl6FX8QPW6NLRYy3Kywp3N6xMtG-3ZqykW52dxC-2mqFDLW75G-JF5j7Pl6W4q6GNn6HCzHVW66mFH-3Bvn2VW5nkkhd30gkmSN7dxz2VSYXv1W4LxrXT6mV_r5W70d4Ls8bdbn9W1b6cWW3Bh574W1cC-YF2sRdzRW19hXNy397P9rW2tKB0c1TYJMDW2FnWq05qwYFhW55z5m335fBX5W1CZjTH5ygr0CVb6GmC26nsTdW7RGCRx7pYcQJW3T1bPn8MZ118N6rTnwCbMT_MW5kSyMZ8PK7-YW5kB3Zr2lrP_536_h1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeVvrVJZL$>



Are you working on a solution that addresses future health threats? BARDA Ventures and Rockies Venture Club invite you to apply for the opportunity to be considered for a 1-on-1 meeting



[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/CTA-Buttons/CTA*20Apply*20Black.png?width=190&height=70&upscale=true&name=CTA*20Apply*20Black.png__;JSUlJQ!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB0tqb4bY$ ]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsF13q0BhV1-WJV7CgJSvW6znyDv5NmXZcW6FgRYn2gpxwQW68K0Gp95vLVVW8G5Fj61McQRkW4WB1JB1g6FLdW2cb82z38clVgW5nbR9k6zNd3MW8VRQvk5X7cTyW8xnVkN2nGBHrVF77xW7jqNvZW3rNkmp8P9m4xW2SdKMk4V59y2W2C1Rt38cqS4KW4hJyyj5LWGQHW7xp7yV7XqJPBW4__tPr38zDGVW5zp0R821YVZgW1rmJ7X55MCDlW7_mrxg7KHY8FW2-3rNX5tlJK5N6HlNVtwZLBZW5Fkkfh5wzgNSW7SyNqV3xgfxfW6gvkZ49hRJVxW8QtB9j7BVZ6qW7lVLrG57nHpd3jdl1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeWqS9JxD$>





[BK Symposium Update]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgJX7W3Rhr5t48N0nVVngwjT6jL73GW8SgJ477rHYSnW4CptCY8KjYKPN23nLZYFj8CtN2p64WQZKj55W8-9rCn6x8cx9W2t1Zzn6tl4KMW8kvJdW4jfVnRW7SnMjs1h7wy-W49Px4R81Kr4sW778J833m6-s6W2CP0Hz1HjzdMW3TjTgp2cY-1FW7k_kfc4rjz04W5gVZcT3XNp_fW1_vgfN5mjx1wW1hyKww7JjYH7N974vwsVX8ZgW71nlVR1dbZ43W3DB6LK31_BcCW4qXL0P4MQJTZ3hVG1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeZw8oKmi$>





More Virtual Events<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgRh5W2X--zn499w_ZW4xwF6w467vwYW4xY2SP49p7jKW4T_c3881XGK7W2_RcDc6tyHhLW5_PQTB7ycJLcW8Fzc1L3txW5yM8h_x5NlFySW6lQvdD121gW_N1BZmQqRnChjW6p-zwr4JBLlYW5Sbj162Gwyj8W42q5625qMy6bVq-bdm55m37mW4fH3Gg2Y7xJ0W31Qrtt3y9CgVW2tRsMQ1TtRXYW5CcrrM3m0r0HN4j9xvcz8PBkW1ZVf5M2N7TxdW732SGw9d0wbfW2Nz4Ch8kQH5n34L41__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeTa7RY9k$>





[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Icons/Clock*20Icon*20-*20Black.png?width=40&height=40&upscale=true&name=Clock*20Icon*20-*20Black.png__;JSUlJSUl!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB3qWjluk$ ]



Sep 9, 8:00am PT



[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Icons/Clock*20Icon*20-*20Black.png?width=40&height=40&upscale=true&name=Clock*20Icon*20-*20Black.png__;JSUlJSUl!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB3qWjluk$ ]



Sep 15, 10:00am PT

Raising Capital and Forming Strategic Partnerships with Industry in the Medical Device Universe<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgDqPW1w48X77H61TTW8sWR2q3ggSnBN1qzLHJfY5cYW6pr7H27l4XLTVz754N7QwJkyW2HtP0Y18hNkhW5xpmJ6759VlcW99jsGf1Qbz9DW47xdNb2BRLRTN6NtLQnk_6kgN2BJZCS2f68RW2Y6PHP2MhVL0V-B3tx8d5s-mW2mn6v62WlWsfN69F8ChTZD0vW1TcqJY6n9rqYW5Z874n4GkmbmW4SWw_g20-qPnW6cM_1m1NN16nW7PxFd_35TzPFVBRGhG7hKpGjW1kvW8K5nykDV3dpp1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeZr9QAoC$>



Building Better Teams by Fostering Equity in the Workplace<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgB7GW6gjMm_9lgKXkW38KvC-5qhgvZW7C48v63Vn2JpW7P9NGJ9hgXbGVL63mv85Tp6rW3fNGpZ5P_h_BW7R4H_B5pqZ5pW3NCQln7x0gvQW1wC20D7RhPZhW4R7M9X3GMW96W2JHXNZ1n1ll1W4YvKBp8ll-SsW97wzGT51MqSwW94wW2q5X-78qVGjHwv6FvL47V-83hB61Q-GBW6JmXZ038nV_xW3vxXRK6v8xpjW8XP6DN8P-rGtW5XL6Xv78-jWCW6hZqbM50XYS4W4ngfWr23sP3L3ktz1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeWwfne35$>

[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Icons/Clock*20Icon*20-*20Black.png?width=40&height=40&upscale=true&name=Clock*20Icon*20-*20Black.png__;JSUlJSUl!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB3qWjluk$ ]



Sep 15, 7:00am PT



[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hub/3988599/hubfs/Icons/Clock*20Icon*20-*20Black.png?width=40&height=40&upscale=true&name=Clock*20Icon*20-*20Black.png__;JSUlJSUl!!LkSTlj0I!TfsNjolhat7BYDO3PdSEFWFgl6wUNI4mMWeR4cRc0rThpmF8zW4bDW4Sy5OB3qWjluk$ ]



Sep 28, 10:15am PT

Antimicrobial Resistance - Breakthrough Innovation and Breaking Barriers<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7CgNGJW6l6DsW2dN88MW5fvlzX6yJNG_N1g8r1vqVsdDW8mwf073Wz2dTW490FCy8pd4TpW8D3-NG3gxKFpN9gR1r62RXq6W62qBKK3gVZvhW1BthmQ8-m0kXW6twQvs9dFgK7W63mjh86Hjj1_N6xKgwKplWW4VSkt_j11tWV-VnRZ001K-k-fW78vN_76gpQwDW3FMKR93BJ3d3W8xSdyz1YwWP9W8Y4XX-28L5S-W1w-q-B935QvMW552bMZ3dl6FwW2nb3wk5_H-P3W1HkZ9_6MYWh238kG1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeXEKhW5A$>*



Battling Chronic Kidney Disease (CKD)<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDL3q0z_V1-WJV7CgPg_W2Js7dw4p3hv1W2F9l8f1GWV0VW8jkK3F8JVVh5W1mg82B5BwZDmW4Xlqms1TPTbtW7nM95T3VrHvhW64kbT-86-6MPW8Tf7-t2kwk_xW3fhL024nf0kSW204hCm8h3xvMW89BKhH85bjRWW5_HMsC7LGctxN61mf23sk_0vW5N0Rbq8Jnjq6W96W51R6WpTKRW5vmXgF4X-w4zW8ZbcSM2pkGzQW98W7kV1KMgxbW3Z4BVP41Q8M6W37ztll4dYSgTW3m53HW1n6g8FW7XHRKm6B-VlkW6RrkKS8W8_cnW8X6CqQ6ZyvbX3h701__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeSqEyEb9$>





[Check out all of our online events ›]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgS-_W17lLmd7njfXWW42WP664xKTsmW561Jtm7_tblnW7TFcDv4khlfPW1qn-hy40TvGbVJcpHY8z7ZFFW2C2GHM1P85LyW8kRD4N5fl03zW5bwykk2f_2vRW5ldB3381kybCW8gJHtk68y2GlW8tgxwf33NL7gW53j42k5Xw4W8N6kXvHMNkB57W8PYzGZ587yp6N8ZqJ-2krFVwW3qpgr76zBhR8W6QpLjd3t_DhlW6Tm03h1Z4CgyW9gW5vx1PpcFCW6_k4nZ1KlvC1W3W73zX3Cn4Q5W99Cm0_37bBFpN5jHnmdkkJG2W6bNG73875yKNW51gr6d3dpHnDW4dNgP51zGQY2W33lPJ982my0xW5D0YpV5m2-3tVscFM93pzgxgW4h2v_q3gMdD2VJmYPn6-8Xy_W11hPsp3gZ3dnW1SWPzF6hv2_HVq4zWC2Y5jmJN5TFxsGbLPn6W56RCKj7ngFJbW2X7wz539lmlWVgdpxK7f1GhVW35YS-f6pvsqRW4_m1sM2r08FMV4c_Wq80ZNJvVGCXVF4dLrlvW8YWS-h4dcRck3hsr1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeZnk0A35$>









Get connected, Follow us



[New call-to-action]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgFTcW6XZr7s7ZcJGJW2kX_xq5WLRPxN6BPw9XYnqGTW6lNLZx40BvzZW5Kw2LL6C-RVKW1b6LwP3r3dsVW5WNdK394P8BWW1LGvpj1c17f1W3dN90j8cQFN_W3ZSc4_2dmWtxW4vZhNM4QyZlvW6_JXxy6HnvmCW4-tQbY7zVgp4N4_tm1dTmyPqW1P67212qCQyTW8w09DK4VmRSyW5mQBwz6NR5SnW30bl0N1g4PxjW4k9FKj7JM35lW8SWzW344djdBN9gktSWzZNk4W7BCSWs7NvKbVW5V0kws2wZ5q1W8SySJd30ghC9W6mQ8v18C5MbcW2v1hx35mKV4LW5YcsRw1kTl7SW1GFMck2DVBTLVTly8c7kcztzW1PXFZV79fB2gW8yfmny1cf7nwN88cBP9M4lXrW82MZ3h5b3Ql_W46QdsN7Ysv6bW44NK1v6LP3_bW8_jKkW4lLd0XW2Bgzc76yZGfcW26bXfd5GfrwMW2BbQm17pVwxrN7xvcH_qf9ckW5P2DPh5DgfQkW2RqvJW1V83QRW4MvNGp5Pl_d7VF-WDB2-VqNH38x11__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeU98-7X7$>



[Yes, continue sending me emails]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgZZWW2tG2T56MvqZ-W6jwT-459YYnnW4RfXP77Dw-lTW2mjw7D8llWLxW20Xjk16Xnb9LW2W_m2p8kwymMW19N4BG25tcZ9MNPb8Pnr4jrW35gM3x1MvQkQW5Rkqmb11kSQvW6cLznN86LyJhM-pfRZ4_NwcN7tJvTR-jGXTW5-gjLp7gw5DNVR3HGN5zKrNqW5RNmRY6dw260N202VP-M9GqfW3xQLp654Nr6PVljSL197H0xVVC8WGZ5KVG7dW8GmpJ35WwWwbW2RJtQm5xxq31W5m_Fh34FS24kW7_RT7L5WHZGTW8pknhy8P8b-hW4J2ygd4JxMbNW6ndHLl1hw4LlW8Djgbd1t39vSW27S7nr4RMHDBN5fW3G4sHxS0W8Pw40Z9jHwJQW8-LJ2v3R2T_sW8gSYCj7GxtZjVvMPm79k5wbxW3X561j25v14lW8q9kmp5-tGFWW4mhtP54qdjsbW8-FkvT6YnCk3W8kzcXK636DjvW4d1Kyb3LcnqfW5QXx8s8SvKC_VwSCsK31RCG_W4R2HQs5wl5w0W8r0DSR8TW3bK37yb1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeRl1psLz$>



[Yes, continue sending me emails]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgKKDVxM6_b187fk7W151WMV6-jpyWW4dM0JW4V3ThxW8X8Vkk7wZTWKV3GRwm84_xmvW3XS3LF4nZ0yvW547WWC893FnwW2dSH_N6_jBsQW66xrV957jCrSW7sN8CV9jH4dSW444gpV5NRj-pN3NtXqng04zsW4gn2NP91N0lwW2008f35YnKpGN4WPn66FQ_wLW2lYSRQ7Zs48sW8RScYj40ZjVBW5zRHg52jDHRbW5wXbKc2NBvtBW11Yl394bYhYbW6l8qfl38WfhKVsTx5_418C54W86JsG55w2pPcW23yslP8Jm-9SW6P90m07t663SW1L8fYR2BHfygW1jSH1t2XJ1srN7tFndGG9b2RW551D4430ZyyqW5s0yH78H__BMW63b7B895t7dyW45g3Z74HPZ_TW3k5wtg2-Qq9lVW_Tt71ZqW0KW3fl0gy24WQ74W7yX9RL5Xwx_yW1Lr6zF6JTB9BW3YyP2n6W_P89W83FWWx7Bb009W4DN5MT78sY_-W6PjCBp5zMRykW1lwtBp9crhwqW966q0B7KVxRdW7s3ZCN5G_ZWF343_1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eea7w5i5o$>



[Yes, continue sending me emails]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgZ0dW7djvhY5CqSrtW28nl2p1C9B65W8D4B4d4nYm-zVKskQq24-7XVVWgzjc7Y-17RN864HrrYs043N5KHjVwjSb32W4vkD4n2lcB61W2jL0t52QC40MW63NHT16wN7JcW98WNgy4Nwf2DW9lc-cf2G4p7-N92G9mSHyqytN26T2JrQhjKWW4p30wn1g-hL9W8slpsB8xHp13W6vsPDG1P0SslW66W6yQ1c_NlqN45gyQpCLPn8W126DxW6-kBKGW9gTbQl6-3cw8N8_Mc2TY9rfbW27ZB018Q79NfVDXr0v5rPVf_W4Cflh47fqskkN6Hh_ZsNHk6hW7-57bs2fCKqSW7F39Gf8fQWq3W8jv1cd7_drjlW7LbvkG7SzB15W2_9C0t42SzsrW8W84Qh22z3ZDW4dhjXt39zD3KN1RJc59gz4s-W2Lf1Vl1vlfljN6l3pHhpdKKCW1lvS_F85vvkfW4JBkDz8WzTZ1W5jzKtJ2rg6xBW2XcdYY6J6-skVPkTBP8pqCXbM3rqQKyf7k1W2nZ-N74CgL9HW46PRB08FRKTx37YX1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeWkLcGKR$>



[Yes, continue sending me emails]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgTyqVCS9xn1Wmg5GVKbKcX70pylkW2_LqXb6w35rFN4V0CngTBWwyN97c1X1hFhsrW4WBsKv4gpPgkW4MMsTW4S5j3KW6NtYdh4V1x4ZW4z-DHd81yGzbVRxB5S1tHMCpW71mmHF855dwyW7KHXgH6DQxWWW4DDVk336m9-bW6Qcvxk3z0YQNW1rK37l6JBjgsW5Xm1yZ3QTLL9W23CWX02kjgRXW3m5BfY14dp-zW8GShhG45MGRWW6zZvvY47fM-BW4hWtpv9jmHCyW7JHpjb6QXyYWW9fkd7p45wdKWW2zhY0D1FVz1BW43cPD93PLvY4W1TVyTZ991-_HW7SlR_t2NGxHMW6VKGvT8gGLDWW1NVQ591PMlw8W58WDvr1bllD1W53dCM91MvpwYW2wXrqk1NKPgBW82fNqT5vWdZXF8qQgGCCkJcW2HPCtv8t6rYXN1c8t5fzZRXPW8MLGkp6XXc7TW4BJk4P7dgRr5W147bgL35mtK_W7lm2SP2gcwZPW8_g-lQ7b2WmNVR4rD21jygQHW3NG38b54HMWwW1Cb_B98mPqQC33rV1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eedBhEyWo$>







New to Johnson & Johnson Innovation or interested in more briefs?



[Yes, continue sending me emails]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsFk5Vbt3V3Zsc37CgW4FW1mWvKS6wDptSW76vF-55T3hj1W7T2zTQ46t_nWW4kVzZx7w_qT2W7mL4Cd1T3rlLW5ZgbLf3FNs7JVhHhPq8gWZvhW6DF3q72vCBxXW3bGp1d96q1sHVzvVJC1_6D-YW8LCt4T1QSWW9W5wSg9X2KSNHbW3SCbx13LGsdNVVz0ZY8m0c34W4RkDFJ5b_kMnW1j6wwY8fkt-dW6VlcYS2TvZ_qW5DwZbP7mZnmBN6T6zWyXr0ggW2JsvKw7L_q5NW24XS4j38CwkzW1gKtRc7TN8wYV-g_BB20PHXrW3ZNhkW1SFyv-VPJ1BC7gqSq7W6DQvXB50nKsNW5SXy4R7LwYCtW6DPqhy4NXzLmW25V84r3Ydr38W1vq8tk38vhVWW7SsMLN1TT9F2W8R-7Gw9lS83DVKStVM10rKy3W8R-gPs2CqpmxW8CQwQN4TYN8tVsXg8x9lRSYWN5tsk0L8T_LhW4x1SJb4G4H7HW1XQV561p1ysgW8ghp9P8W6yR8W74SnGY3FbwrRW7-TLxP5TrZYqW4mDzlq7_xtj_W1_hcgl3Ll3Q736wL1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeXEL-k40$>







*This program is part of BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA).

© Johnson & Johnson Innovation 2021.
Johnson & Johnson Innovation  1 Johnson & Johnson Plaza    New Brunswick  NJ  08901  USA
You received this email because you are subscribed to Regional Brief from Johnson & Johnson Innovation.
Update your profile<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VWmD3R6MPMxnW4C3_t41V46b0W5g6HvJ4wqKwTN8JCsDr3q0zJV1-WJV7Cg-_sW32HvPV3PM4VkW6_XGbg74SpfQW6-vm0Z9kZZT-W5mBN_53PCHYvW6L2x-S46-RhDW6Fhm019bycTbVX6LXh4pHmyrW2p9Jb_4X52c1W6JNDv12nMP3QW1SgK3j6JsDVMW8Qck0z5p_8rlW1MXhGg2wrBLZW592T3c2XvFT9W292sPj5dSFLXW5Yh0RW52HB0BW8W3VBb1z4YHBW4fR_jm26DMZHW4LhP4097cgvHW1FlzVp5HCkVpW5pkDwv1-hct0W8pT7j64pJRpkT21sf2clg_63ld_1__;!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eebJU8VG7$> to choose the types of emails you receive or unsubscribe from future emails<https://urldefense.com/v3/__https:/hs-3988599.s.hubspotemail.net/hs/manage-preferences/unsubscribe?d=VnbTNN6MXH38VCsNKB3R5JYDW3JH5dN3Qz74WW4h2dR05DV1tyVmWFdj7mK51NN7gxRXn25DmvW51sgh55QH97mVXbzgh92MmnTMXk_7Qbw1sfW36MG2C3tKWTjW8x7L9X5XH3B43nlf2&v=3&utm_campaign=WCS*20US*20Weekly&utm_source=hs_email&utm_medium=email&utm_content=150586274&_hsenc=p2ANqtz--WU5XjKbmvyasfSRTwf8LCjtzAKOF_h66BDP6Be2E5xSITBfJvOGW7CkG33hGwC57lbpvQVAdQsdyWMqCpgSjXChM6bw&_hsmi=150586274__;JSU!!LkSTlj0I!XY43oOob12dxKeZZ5qlxmwRFMlv_PCdbQtE98vGa5Xvb9_ozDi3Xib-eeVi5SuM0$>

This email is from Johnson & Johnson Innovation and represents a selection of activities from across our Innovation Centers, JLABS and JJDC. The information in this email is for informational purposes only. The information is either proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies ("JJI and Johnson & Johnson") or is provided by or proprietary to third parties. In case of third party information, please note that only those third parties that provided or own this information are responsible for it. By providing this information, JJI and Johnson & Johnson do not endorse these third parties or any of the information provided in this email. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of JJI or Johnson & Johnson. JJI and Johnson & Johnson are not responsible or liable for any actions you do or do not take in relation to this information and are not responsible for any use of this information by you. By providing the information in this email, JJI and Johnson & Johnson do not make any representations, warranties, or assurances, express or implied, as to the content or the information presented in this email and is not responsible for any use by or alterations of this information by you. JJI and Johnson & Johnson hereby expressly disclaim any and all guarantees, representations, warranties, or assurances and assumes no responsibility or liability, direct or indirect in relation to the information in this email.








-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://Bug.EGR.UH.EDU/pipermail/engi-dist/attachments/20210819/9ba52102/attachment-0001.html